Reports
Sale
Global Eye Care Market Size, Share, Trends, Growth, Forecast: By Product Type: Eyeglasses, Contact Lens, Intraocular Lens, Eye Drops, Others; By Lens Coating: Anti-Glare, UV, Others; By Lens Material: Normal Glass, Polycarbonate, Trivex, Others; By Indications; By Distribution Channel; Regional Analysis; Market Dynamics; Supplier Landscape; 2024-2032
Global Eye Care Market Outlook
The global eye care market size was valued at USD 118 billion in 2023, driven by the increasing prevalence of eye diseases and pollution across the globe. The market size is anticipated to grow at a CAGR of 5% during the forecast period of 2024-2032 to achieve a value of USD 182.5 billion by 2032.
Global Eye Care Market Overview
Eye care refers to the routine, steps, or instructions that an individual follows to take care of their eyes. Eye care products comprise of glasses, lenses, and medicated drops, among others, which can help protect eyes. Other than using these products, eye care also means regular eye check-ups, eating healthy, and wearing protective glasses or lenses. Eye care is necessary in everyday life to ensure a long and healthy life of eyes, which may refer the clear vision, healthy eyesight, and the absence of eye diseases in an individual.
`The development of technologically advanced eye care products is primarily driving the eye care market growth. The demand for eye care products is constantly rising due to the introduction of advanced technologies like artificial intelligence, virtual reality, and telemedicine. These technologies are increasingly being adopted by healthcare professionals and manufacturers in the development of eye care devices that are useful and effective for patients suffering from eye diseases. The rising promotion of regular eye check-ups, along with the increasing awareness about UV protection and healthy lifestyles to achieve and protect healthy eyes is also contributing to the market.
The rising prevalence of eye diseases, along with the increasing geriatric population across the globe, are some of the key factors propelling the growth of the market. Every technology comes with its pros and cons. While devices and gadgets have made a lot of things much easier and manageable, people have started spending excessive amounts of time looking at their screens, which is one of the primary factors causing weak eyesight and other eye disorders. This has further propelled the demand for eye care.
The improved healthcare infrastructure across the globe has directly contributed to the eye care market development. The increasing availability of affordable and effective eye care treatment and devices to protect eyes against UV rays has provided significant impetus to the growth of the market. The rising awareness about eye care globally has directly influenced the continuous growth of the market.
Rising Prevalence of Eye Diseases
Vision plays a crucial role in everyone’s life. Vision impairment is a common medical condition when a person’s vision is compromised to some degree to complete vision loss. The leading causes of vision impairment and blindness at a global level are refractive errors and cataracts. It is estimated by the World Health Organization that 2.2 billion people suffer from near or distant vision impairment. WHO also emphasizes that in around 1 billion of these cases, it could have been prevented or has not even been addressed yet. Even after the available treatments and eye care facilities across the globe, WHO estimates, that Only 36% of individuals with a refractive error-related vision impairment and just 17% of those with a cataract-related vision impairment have received appropriate interventions.
Due to vision impairment among people, this condition poses an enormous loss of productivity globally costing around a whopping estimate of USD 411 billion. The data reflects an urgency to overcome this dominating condition causing economic wealth and compromising people’s health due to underlying factors. Vision impairment can be prevented and treated if appropriate interventions are accessible and affordable which may further boost the global eye care market.
Rising Innovation and Developments
In July 2023, a group of students from the Ramaiah Institute of Technology’s IEEE Computational Intelligence Society chapter in Bangalore, India, developed a device OurVision, to assist visually impaired people. These students applied computer vision techniques to develop a low-cost wearable that reads text out loud to users in any lighting conditions and helps them navigate their surroundings. The advanced technologies used to develop OurVision include optical character recognition, machine learning, and Google application programming interfaces. With this device, people with vision impairment can enhance their academic and career opportunities, along with living individually. Along with the technologies, this device is enabled to translate text into 6 different languages including English, Kannada, Telugu, Malayalam, Tamil, and Hindi.
The IEEE CIS chapter received a USD 4,400 grant for the project from EPICS in IEEE. The student team was able to take an idea and turn it into a working solution while working hand in hand with a community partner, the National Association for the Blind (NAB) in Karnataka, India.
Development of such wearable devices that are low in cost and highly advanced are likely to contribute to rising eye care market share and may even attract investors to further develop the product on a larger scale to make it available in the market followed by regulatory approvals and other formalities. Successful approval and distribution of this device in India could pave the way for global expansion of the market.
Strategic Moves by the Market Players Poised to Aid the Market
In June 2023, Syncona Limited launched Beacon Therapeutics Holdings Limited, a gene therapy company focused on restoring and improving vision in patients with prevalent and rare blinding retinal diseases, including X-linked retinitis pigmentosa (XLRP). Syncona gathered with Oxford Science Enterprises and raised USD 120 million (£96 million) to acquire AGTC, which is a publicly traded biotechnology company focused on developing genetic therapies for rare inherited conditions and providing capital for operations and development of newly formed Beacon Therapeutics.
Beacon Therapeutics’ pipeline inventory includes AGTC-501, a late-stage and lead development candidate for XLRP (caused by mutations in the RPGR gene), as well as two Syncona-owned preclinical programs that target Dry age-related macular degeneration (AMD) and Cone-rod dystrophy (CRD), in-licensed from the University of Oxford. The company has affirmed the efficacy and favorable safety profile for the AGTC-501 in the report of the phase 1/2 HORIZON trial.
Additionally, Beacon Therapeutics is developing an intravitreally delivered novel adeno-associated viruses (AAV)-based program for dry AMD that can be administered within an outpatient clinic rather than via surgery. However, for CRD the program targets mutations in the Cadherin Family Related Member 1 (CDHR1) gene which is a potential cause for central vision loss (akin to dry AMD).
Global Eye Care Market Segmentations
Market Breakup by Product Type
- Eyeglasses
- Single Vision
- Bifocal
- Progressive
- Contact Lens
- Personalized/Custom
- Specific Care
- Single Vision
- Progressive Lenses
- Activity Lenses
- Intraocular Lens
- Traditional
- Premium
- Phakic
- Eye Drops
- Others
Market Breakup by Lens Coating
- Anti-Glare
- UV
- Others
Market Breakup by Lens Material
- Normal Glass
- Polycarbonate
- Trivex
- Others
Market Breakup by Indications
- Refractive Error
- Glaucoma
- Diabetic Retinopathy
- Amblyopia
- Dry Eyes
- Others
Market Breakup by Distribution Channel
- Online Stores
- Retail Stores
- Hospitals
- Clinics
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Eye Care Market Regional Analysis
North America has been leading the global market for eye care and is likely to continue dominating the market due to the rising prevalence of eye diseases in the region. According to the Centers for Disease Control and Prevention, it is estimated that nearly 12 million people aged 40 years and over in the United States are currently living with vision impairment, including 1 million blind people, 3 million with vision impairment after correction, and 8 million with vision impairment due to uncorrected refractive error.
In January 2023, a Canada-based leading vision-enhancement platform eSight, launched its latest innovation in assistive technology, eSight Go. The wearable device sets a new standard for enhanced vision technology through its heightened visual clarity, lightweight design, and expansive field of view, helping those with central vision loss gain independence in their everyday life.
Innovation exemplified by eSight Go may help overcome the global eye care market challenges and may enhance the market value during the forecast period. Such innovations in assisted technologies are poised to enable people with vision impairment to live an independent life with enhanced vision clarity and field view.
Global Eye Care Market: Competitor Landscape
In June 2023, Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, announced the launch of Bausch + Lomb INFUSE® Multifocal silicone hydrogel (SiHy) daily disposable contact lenses for patients with presbyopia in the United States. These lenses feature a next-generation material infused with ProBalance Technology™ for all-day comfort and the company’s unique 3-Zone Progressive™ design to deliver clear vision with seamless transitions across near, intermediate, and distance vision while helping to minimize contact lens dryness.
The key features of the eye care market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- CooperVision Inc.
- Johnson & Johnson Vision Care, Inc.
- HOYA
- LUXOTTICA GROUP
- Novartis AG
- Bausch & Lomb Incorporated
- Menicon Co., Ltd.
- Carl Zeiss AG
- Valeant Pharmaceutical International Inc
- Zydus Cadila
- Rayner Intraocular Lenses Limited
- GrandVision
- Blanchard Lab
- Avizor SA
- F. Hoffmann-La Roche AG
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Lens Coating |
|
| Breakup by Lens Material |
|
| Breakup by Indications |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Eye Care Market (2017-2032) Overview
3.1 Global Eye Care Market Historical Value (2017-2023)
3.2 Global Eye Care Market Forecast Value (2024-2032)
4 Global Eye Care Market (2017-2032) Landscape*
4.1 Global Eye Care Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Eye Care Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Indications
5 Global Interventional Radiology Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Eye Care Market (2017-2032) Segmentation
6.1 Global Eye Care Market (2017-2032) by Product Type
6.1.1 Market Overview
6.1.2 Eyeglasses
6.1.2.1 Single Vision
6.1.2.2 Bifocal
6.1.2.3 Progressive
6.1.3 Contact Lens
6.1.3.1 Personalized/Custom
6.1.3.2 Specific Care
6.1.3.3 Single Vision
6.1.3.4 Progressive Lenses
6.1.3.5 Activity Lenses
6.1.4 Intraocular Lens
6.1.4.1 Traditional
6.1.4.2 Premium
6.1.4.3 Phakic
6.1.5 Eye Drops
6.1.6 Others
6.2 Global Eye Care Market (2017-2032) by Lens Coating
6.2.1 Market Overview
6.2.2 Anti-Glare
6.2.3 UV
6.2.4 Others
6.3 Global Eye Care Market (2017-2032) by Lens Material
6.3.1 Market Overview
6.3.2 Normal Glass
6.3.3 Polycarbonate
6.3.4 Trivex
6.3.5 Others
6.4 Global Eye Care Market (2017-2032) by Indications
6.4.1 Market Overview
6.4.2 Refractive Error
6.4.3 Glaucoma
6.4.4 Diabetic Retinopathy
6.4.5 Amblyopia
6.4.6 Dry Eyes
6.4.7 Others
6.5 Global Eye Care Market (2017-2032) by Distribution Channel
6.5.1 Market Overview
6.5.2 Online Stores
6.5.3 Retail Stores
6.5.4 Hospitals
6.5.5 Clinics
6.5.6 Others
6.6 Global Eye Care Market (2017-2032) by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Eye Care Market (2017-2032)
7.1 North America Eye Care Market (2017-2032) by Product Type
7.1.1 Market Overview
7.1.2 Eyeglasses
7.1.2.1 Single Vision
7.1.2.2 Bifocal
7.1.2.3 Progressive
7.1.3 Contact Lens
7.1.3.1 Personalized/Custom
7.1.3.2 Specific Care
7.1.3.3 Single Vision
7.1.3.4 Progressive Lenses
7.1.3.5 Activity Lenses
7.1.4 Intraocular Lens
7.1.4.1 Traditional
7.1.4.2 Premium
7.1.4.3 Phakic
7.1.5 Eye Drops
7.1.6 Others
7.2 North America Eye Care Market (2017-2032) by Lens Coating
7.2.1 Market Overview
7.2.2 Anti-Glare
7.2.3 UV
7.2.4 Others
7.3 North America Eye Care Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Eye Care Market (2017-2032)
8.1 Europe Eye Care Market (2017-2032) by Product Type
8.1.1 Market Overview
8.1.2 Eyeglasses
8.1.2.1 Single Vision
8.1.2.2 Bifocal
8.1.2.3 Progressive
8.1.3 Contact Lens
8.1.3.1 Personalized/Custom
8.1.3.2 Specific Care
8.1.3.3 Single Vision
8.1.3.4 Progressive Lenses
8.1.3.5 Activity Lenses
8.1.4 Intraocular Lens
8.1.4.1 Traditional
8.1.4.2 Premium
8.1.4.3 Phakic
8.1.5 Eye Drops
8.1.6 Others
8.2 Europe Eye Care Market (2017-2032) by Lens Coating
8.2.1 Market Overview
8.2.2 Anti-Glare
8.2.3 UV
8.2.4 Others
8.3 Europe Eye Care Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Eye Care Market (2017-2032)
9.1 Asia Pacific Eye Care Market (2017-2032) by Product Type
9.1.1 Market Overview
9.1.2 Eyeglasses
9.1.2.1 Single Vision
9.1.2.2 Bifocal
9.1.2.3 Progressive
9.1.3 Contact Lens
9.1.3.1 Personalized/Custom
9.1.3.2 Specific Care
9.1.3.3 Single Vision
9.1.3.4 Progressive Lenses
9.1.3.5 Activity Lenses
9.1.4 Intraocular Lens
9.1.4.1 Traditional
9.1.4.2 Premium
9.1.4.3 Phakic
9.1.5 Eye Drops
9.1.6 Others
9.2 Asia Pacific Eye Care Market (2017-2032) by Lens Coating
9.2.1 Market Overview
9.2.2 Anti-Glare
9.2.3 UV
9.2.4 Others
9.3 Asia Pacific Eye Care Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 Australia
9.3.5 ASEAN
9.3.6 Others
10 Latin America Eye Care Market (2017-2032)
10.1 Latin America Eye Care Market (2017-2032) by Product Type
10.1.1 Market Overview
10.1.2 Eyeglasses
10.1.2.1 Single Vision
10.1.2.2 Bifocal
10.1.2.3 Progressive
10.1.3 Contact Lens
10.1.3.1 Personalized/Custom
10.1.3.2 Specific Care
10.1.3.3 Single Vision
10.1.3.4 Progressive Lenses
10.1.3.5 Activity Lenses
10.1.4 Intraocular Lens
10.1.4.1 Traditional
10.1.4.2 Premium
10.1.4.3 Phakic
10.2 Latin America Eye Care Market (2017-2032) by Lens Coating
10.2.1 Market Overview
10.2.2 Anti-Glare
10.2.3 UV
10.2.4 Others
10.3 Latin America Eye Care Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Eye Care Market (2017-2032)
11.1 Middle East and Africa Eye Care Market (2017-2032) by Product Type
11.1.1 Market Overview
11.1.2 Eyeglasses
11.1.2.1 Single Vision
11.1.2.2 Bifocal
11.1.2.3 Progressive
11.1.3 Contact Lens
11.1.3.1 Personalized/Custom
11.1.3.2 Specific Care
11.1.3.3 Single Vision
11.1.3.4 Progressive Lenses
11.1.3.5 Activity Lenses
11.1.4 Intraocular Lens
11.1.4.1 Traditional
11.1.4.2 Premium
11.1.4.3 Phakic
11.1.5 Eye Drops
11.1.6 Others
11.2 Middle East and Africa Eye Care Market (2017-2032) by Lens Coating
11.2.1 Market Overview
11.2.2 Anti-Glare
11.2.3 UV
11.2.4 Others
11.3 Middle East and Africa Eye Care Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 CooperVision Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Johnson & Johnson Vision Care, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 HOYA
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 LUXOTTICA GROUP
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Novartis AG
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Bausch & Lomb Incorporated
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Menicon Co., Ltd.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Carl Zeiss AG
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Valeant Pharmaceutical International Inc
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Zydus Cadila
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Rayner Intraocular Lenses Limited
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 GrandVision
17.12.1 Financial Analysis
17.12.2 ProductPortfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Blanchard Lab
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Avizor SA
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 F. Hoffmann-La Roche AG
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
List not exhaustive
18 Global Eye Care Market (2017-2032) - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The market attained a value of about USD 118 billion in 2023, driven by the rising prevalence of eye disorders.
The global eye care market size is anticipated to grow at a CAGR of 5% during the forecast period of 2024-2032 and reach a market value of USD 182.5 billion by 2032.
The increasing prevalence of different ocular diseases, rising geriatric population, increasing screen time, rising number of people with weak eyesight, and rising disposable incomes, strategic moves by companies, product launches to cure vision impairment, innovation, and development by enthusiasts at college, funding/grant activities are some of the key factors aiding the growth of the market.
The increasing technological advancement and companies launching ventures targeting vision impairment among people is a major trend aiding the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
The different types of products in the market are eyeglasses, contact lenses, intraocular lenses, and eye drops, among others.
The different types of lens coating in eye care products are anti-glare and UV, among others.
The types of lens material in the market are normal glass, polycarbonate, and trivex, among others.
Eye care products find wide applications in corrective, therapeutic, cosmetic, prosthetic, and lifestyle-oriented, among others.
The indications include refractive error, glaucoma, diabetic retinopathy, amblyopia, and dry eyes, among others.
The different distribution channels in the market are online stores, retail stores, hospitals, and clinics, among others.
Key players involved in the market are CooperVision Inc., Johnson & Johnson Vision Care, Inc., HOYA, LUXOTTICA GROUP, Novartis AG, Bausch & Lomb Incorporated, Menicon Co., Ltd., Carl Zeiss AG, Valeant Pharmaceutical International Inc, Zydus Cadila, Rayner Intraocular Lenses Limited, GrandVision, Blanchard Lab, Avizor SA, and F. Hoffmann-La Roche AG.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER